Atomo Diagnostics Ltd. Statistics
Want to see AU:AT1 full AI Analyst Report?
Atomo Diagnostics Ltd. (AT1) Stock Statistics & Valuation Metrics
Total Valuation
Atomo Diagnostics Ltd. has a market cap or net worth of AUD 10.83M. The enterprise value is AUD 11.18M.
- Market Cap
- AUD 10.83M
- Enterprise Value
- AUD 11.18M
Share Statistics
Atomo Diagnostics Ltd. has 902,432,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 902,432,860
- Owned by Insiders
- 8.35%
- Owned by Institutions
- ―
Financial Efficiency
Atomo Diagnostics Ltd.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -51.37%.
- Return on Equity (ROE)
- -0.46
- Return on Assets (ROA)
- -0.32
- Return on Invested Capital (ROIC)
- -51.37%
- Return on Capital Employed (ROCE)
- -0.72
- Revenue Per Employee
- 62.75K
- Profits Per Employee
- -41.34K
- Employee Count
- 85
- Asset Turnover
- 0.49
- Inventory Turnover
- 3.94
Valuation Ratios
The current PE Ratio of Atomo Diagnostics Ltd. is -2.86. Atomo Diagnostics Ltd.’s PEG ratio is -0.05.
- PE Ratio
- -2.86
- PS Ratio
- 2.03
- PB Ratio
- 1.33
- Price to FCF
- -3.18
- Price to Operating Cash Flow
- -3.04
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Atomo Diagnostics Ltd. had revenue of 5.33M and earned -3.51M in profits. Earnings per share was -0.00.
- Revenue
- 5.33M
- Gross Profit
- -2.43M
- Operating Income
- -5.69M
- Pretax Income
- -4.77M
- Net Income
- -3.51M
- EBITDA
- -4.26M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -3.37M and capital expenditures -35,324, giving a free cash flow of -3.40M billion.
- Operating Cash Flow
- -3.37M
- Free Cash Flow
- -3.40M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Atomo Diagnostics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -31.43%
- Earnings Yield
- -34.29%
Stock Price Statistics
- Beta
- 0.52
- 52-Week Price Change
- -55.56%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 36.14
- Average Volume (3m)
- 1.86M
Important Dates
Atomo Diagnostics Ltd. upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 30, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Atomo Diagnostics Ltd. as a current ratio of 3.04, with Debt / Equity ratio of 4.84%
- Current Ratio
- 3.04
- Quick Ratio
- 2.37
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.78
- Interest Coverage Ratio
- -385.92
Taxes
In the past 12 months, Atomo Diagnostics Ltd. has paid -1.26M in taxes.
- Income Tax
- -1.26M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Atomo Diagnostics Ltd. EV to EBITDA ratio is -1.76, with an EV/FCF ratio of -2.20.
- EV to Sales
- 1.40
- EV to EBITDA
- -1.76
- EV to Free Cash Flow
- -2.20
- EV to Operating Cash Flow
- -2.22
Balance Sheet
Atomo Diagnostics Ltd. has AUD 3.71M in cash and marketable securities with AUD 373.08K in debt, giving a net cash position of AUD 3.34M billion.
- Cash & Marketable Securities
- AUD 3.71M
- Total Debt
- AUD 373.08K
- Net Cash
- AUD 3.34M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.01
Margins
Gross margin is -45.56%, with operating margin of -106.65%, and net profit margin of -65.87%.
- Gross Margin
- -45.56%
- Operating Margin
- -106.65%
- Pretax Margin
- -89.51%
- Net Profit Margin
- -65.87%
- EBITDA Margin
- -79.86%
- EBIT Margin
- -106.65%
Analyst Forecast
The average price target for Atomo Diagnostics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 40.65%
- EPS Growth Forecast
- 45.45%
Scores
- Smart Score
- 2
- AI Score
- 46

